Role of anti-SARS-CoV T cell response in pathogenesis
Role of anti-SARS-CoV T cell response in pathogenesis
批准号:
8663180
负责人:
Stanley Perlman
金额:
$37.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2016-05-31
关键词:
AcuteAcute Lung InjuryAddressAgeAgonistAnimal ModelAnimalsCell physiologyCellsCessation of lifeClinicalCoronavirusDefectDendritic CellsDendritic cell activationDependenceDevelopmentDinoprostoneDiseaseDisease OutbreaksElderlyEmployee StrikesExhibitsFunctional disorderGenerationsGoalsGrantImmune responseInbred BALB C MiceIndividualInfectionInfluenza A virusLungLung diseasesModelingMorbidity - disease rateMusOutcomePathogenesisPatientsPoly I-CPopulationPredispositionPrincipal InvestigatorProstaglandinsRegulatory T-LymphocyteReportingRespiratory Tract InfectionsRespiratory physiologyRespiratory syncytial virusRoleSeriesSevere Acute Respiratory SyndromeSeverity of illnessT cell responseT-LymphocyteTimeViralVirusVirus DiseasesWest Nile virusage relatedagedbasecell motilityimprovedlipid mediatorlymph nodesmigrationmortalitynew therapeutic targetnovelpathogenprogramsresearch studyrespiratoryrespiratory infection virusrespiratory virus
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Many viral infections are more severe in aged compared to young populations. This was strikingly illustrated in the 2002-2003 outbreak of the Severe Acute Respiratory Syndrome (SARS), in which >50% of patients who were over 60 year old died while no deaths occurred in those under 24 years. A nearly identical steep age dependence in susceptibility is also observed in mice infected with mouse-adapted strains of SARS-coronavirus (SARS-CoV), making this a useful model for identifying defects in the host immune response in aged mice. Our preliminary results suggest that migration of respiratory dendritic cells (rDC) to draining lymph nodes (DLN) is defective in aged SARS-CoV-infected mice, resulting in a poor anti-virus T cell response, poor virus clearance and increased lung damage as well as increased mortality. Pre-treatment with poly I:C reverses the increased morbidity and mortality observed in these aged infected mice. The central hypothesis of this proposal is that age-dependent changes in rDC function and subsequent T cell responses are critical for the poor outcomes observed in aged populations with respiratory virus infections. This objective will be approached in the following specific aims. Aim 1. To determine the extent to which the defective T cell response in SARS-CoV- infected 12-14m mice is T cell-intrinsic. Defects in rDC migration to the DLN inhibit the generation of a robust T cell response, but this observation does not preclude additional T cell- intrinsic defects contributing to severe disease. This possibility will be investigated. Aim 2. To investigate the basis and time of onset of rDC dysfunction in old mice. The goals of this aim will be to determine if additional defects in rDC function exist in SARS-CoV-infected aged mice and determine the basis of these defects. The mechanism of action of poly I:C, which is protective, will be investigated. Finally, age-dependent changes in the function of specific lipid mediators such as prostaglandin E2, which are critical for efficient rDC migration to DLN, will be analyzed. Aim 3. To determine whether defective rDC function is common in aged mice infected with respiratory pathogens. A key goal of the proposal is to examine the generality of our results by determining whether rDC function and consequent anti-virus T cell responses are compromised in mice infected with other respiratory viruses, such as influenza A virus, respiratory syncytial virus or MHV-1, a pneumotropic murine coronavirus. Identification of rDC defects as critical in the increased susceptibility to viral respiratory infections will provide a novel therapeutic target in infected patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of eicosanoids in pathogenic human CoV infections
-
批准号:9764251
-
项目类别:
-
资助金额:$54.52万
-
财政年份:2016
-
负责人:Stanley Perlman
-
依托单位:
Role of eicosanoids in pathogenic human CoV infections
-
批准号:9542722
-
项目类别:
-
资助金额:$54.52万
-
财政年份:2016
-
负责人:Stanley Perlman
-
依托单位:
Role of anti-SARS-CoV T cell response in pathogenesis
-
批准号:8847630
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
Animal Core
-
批准号:8055144
-
项目类别:
-
资助金额:$22.62万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
Role of anti-SARS-CoV T cell response in pathogenesis
-
批准号:8164278
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
Role of anti-SARS-CoV T cell response in pathogenesis
-
批准号:8264955
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
Role of anti-SARS-CoV T cell response in pathogenesis
-
批准号:8055138
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
Role of anti-SARS-CoV T cell response in pathogenesis
-
批准号:8468102
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
Administrative Core
-
批准号:8055145
-
项目类别:
-
资助金额:$13.24万
-
财政年份:2011
-
负责人:Stanley Perlman
-
依托单位:
A novel strategy for developing a SARS-CoV vaccine
-
批准号:7904591
-
项目类别:
-
资助金额:$40.33万
-
财政年份:2009
-
负责人:Stanley Perlman
-
依托单位:
PPG: SARS-CoV-host cell interactions and vaccine development
-
批准号:8304203
-
项目类别:
-
资助金额:$159.58万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
PPG: SARS-CoV-host cell interactions and vaccine development
-
批准号:8021280
-
项目类别:
-
资助金额:$159.97万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
PPG: HOST VIRUS INTERACTIONS IN HCoV-SARS INFECTIONS
-
批准号:7120540
-
项目类别:
-
资助金额:$144.54万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
PPG: SARS-CoV-host cell interactions and vaccine development
-
批准号:9752412
-
项目类别:
-
资助金额:$125.43万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
PPG: SARS-CoV-host cell interactions and vaccine development
-
批准号:8881046
-
项目类别:
-
资助金额:$159.58万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
Project 1
-
批准号:10229390
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
PPG: SARS-CoV-host cell interactions and vaccine development
-
批准号:8494515
-
项目类别:
-
资助金额:$160.57万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
Project 4
-
批准号:9209901
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
Development of Murine Model for SARS-CoV Pathogenesis
-
批准号:6825517
-
项目类别:
-
资助金额:$28.54万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
Project-004
-
批准号:10229091
-
项目类别:
-
资助金额:$18.24万
-
财政年份:2004
-
负责人:Stanley Perlman
-
依托单位:
海外基金